Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alpha-blockers and Finasteride effectively manage BPH symptoms long-term.

Older parental age, rural living, and specific genetic mutations increase hypospadias risk in children.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

A new method using a Foley catheter on a ureteroscope makes difficult urethral catheterization easier and more effective.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Anabolic steroid abuse can cause sexual, fertility, and health problems.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Skin problems are common in kidney disease, with dry skin and itching in patients not on dialysis or on hemodialysis, and infections most common in transplant recipients.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

The document suggests that drugs for prostate issues might cause lasting sexual, mental, and physical health problems due to blood vessel damage in the penis.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Peripheral treatments showed some improvement in sexual dysfunction, but central symptoms remain challenging.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Antibiotic resistance in children's UTIs, especially from E. coli, is rising due to misuse and easy access to antibiotics.

Genetic mutations can affect female sexual development, requiring personalized medical care.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

Urinary PSA could be an early marker for enlarged prostate.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.